Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
George B. Abercrombie currently holds 49,933 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George B. Abercrombie has been a net seller of BCRX stock. They have purchased $22.3K and sold $2.1M worth of shares.
George B. Abercrombie's most recent insider trade was on Jun 12, 2024, when they sold 49,933 shares at $0.00 per share.
George B. Abercrombie serves as Executive at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 48 insider transactions totaling $2.1M over their tenure at the company.
George B. Abercrombie holds the position of Executive at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
George B. Abercrombie has shown a selling trading pattern, with $22.3K in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by George B. Abercrombie was on Sep 10, 2021, when they sold $1.1M worth of BCRX shares. This transaction involved 74,000 shares at $15.09 per share.
George B. Abercrombie currently owns 49,933 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of George B. Abercrombie's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. George B. Abercrombie has 48 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for George B. Abercrombie and 40,000+ other insiders.